TriSalus completes warrant exchange; 78.9% of public warrants tendered; warrant amendment enacted

TriSalus Life Sciences, Inc.

6,533,614 Public Warrants (78.89%) tendered for 0.30 shares each; settlement by July 1, 2024.
504,685 Private Placement Warrants (10.23%) and 0 Working Capital Warrants tendered.
Warrant Amendment approved for Public Warrants; allows company to force conversion of remaining warrants at 0.27 shares (10% discount).
Registration statement on Form S-4 declared effective by SEC on June 25, 2024.

item 1.01 item 3.03 item 5.07 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.